Low density lipoprotein-containing circulating immune complexes have better prognostic value in carotid intima-media thickness progression than other lipid parameters

International Journal of Cardiology

Volumn 166, Issue 3, 2013, Pages 747-748

  Sobenin, Igor A ^a,b   Orekhova, Varvara A ^a   Melnichenko, Alexandra A ^a,c   Bobryshev, Yuri V ^b,c,d   Orekhov, Alexander N ^b,c  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c Institute for Atherosclerosis Research   (Russian Federation)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Carotid intima media thickness progression; Circulating immune complexes; Low density lipoprotein containing; Prognostic value

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; ANTIGEN ANTIBODY COMPLEX;

ANTIGEN ANTIBODY COMPLEX; ARTERIAL WALL THICKNESS; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; DISEASE COURSE; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SUDDEN DEATH; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CORONARY DISEASE; FOLLOW UP; IMMUNOLOGY; CORONARY ARTERY DISEASE;

ANTIGEN-ANTIBODY COMPLEX; CAROTID INTIMA-MEDIA THICKNESS; CORONARY DISEASE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEINS, LDL; MALE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84893452646     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.175     Document Type: Article

References (8)

1. Tertov VV, Orekhov AN, Kacharava AG, Sobenin IA, Perova NV, Smirnov VN. Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis. Exp Mol Pathol 1990; 52: 300-8.
2. Orekhov AN, Kalenich OS, Tertov VV, et al. Diagnostic value of immune cholesterol as a marker for atherosclerosis. J Cardiovasc Risk 1995; 2: 459-66.
3. Tertov VV, Sobenin IA, Orekhov AN, Jaakkola O, Solakivi T, Nikkari T. Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis 1996; 122: 191-9.
4. Lopes-Virella MF, McHenry MB, Lipsitz S, et al. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis 2007; 190: 359-69.
5. Lopes-Virella MF, Hunt KJ, Baker NL, Lachin J, Nathan DM, Virella G. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Diabetes 2011; 60: 582-9.
6. Odell PM, Anderson KM, Kannel WB. New models for predicting cardiovascular events. J Clin Epidemiol 1994; 47: 583-92.
7. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002; 105: 310-5.
8. Salonen R, Nyyssönen K, Porkkala E, et al. A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995; 92: 1758-64.